Regeneron · 2 months ago
Specialist, Global Procurement - FC&L
Regeneron Pharmaceuticals is seeking a Specialist for their Global Procurement team focusing on Facilities, Capital & Logistics. The role involves supporting category strategy, facilitating negotiations, and managing supplier relationships to meet global and regional business needs.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Supporting negotiations, supplier management activities, and stakeholder engagement activities
Working collaboratively with teammates as well as cross-functionally with stakeholders across all Regeneron campuses
Drafting contracts (regional/global), while working with internal legal department
Provide analysis of supplier spend in support of the Sourcing Manager category strategy
Qualification
Required
Bachelor's degree in a relevant field of study
3+ years of relevant, progressive experience in procurement
Ability to leverage standard business applications for communicating, presenting and analyzing (Word, Excel, PowerPoint)
Preferred
Experience within facilities categories and or life science
Working knowledge of sourcing contracting tools, ERP's, and eRFx systems (Oracle, Zycus, Ariba, Other)
Benefits
Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Recent News
2026-01-08
2026-01-07
Company data provided by crunchbase